Kooman & Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $645K | Buy |
3,476
+40
| +1% | +$7.43K | 0.22% | 25 |
|
|
2025
Q1 | $720K | Buy |
3,436
+25
| +0.7% | +$5.24K | 0.26% | 22 |
|
|
2024
Q4 | $606K | Buy |
3,411
+195
| +6% | +$34.7K | 0.22% | 25 |
|
|
2024
Q3 | $635K | Sell |
3,216
-14
| -0.4% | -$2.77K | 0.23% | 24 |
|
|
2024
Q2 | $554K | Sell |
3,230
-16
| -0.5% | -$2.74K | 0.22% | 24 |
|
|
2024
Q1 | $591K | Sell |
3,246
-132
| -4% | -$24K | 0.25% | 23 |
|
|
2023
Q4 | $523K | Buy |
3,378
+36
| +1% | +$5.58K | 0.23% | 26 |
|
|
2023
Q3 | $498K | Buy |
3,342
+13
| +0.4% | +$1.94K | 0.25% | 25 |
|
|
2023
Q2 | $449K | Sell |
3,329
-207
| -6% | -$27.9K | 0.22% | 26 |
|
|
2023
Q1 | $564K | Buy |
3,536
+15
| +0.4% | +$2.39K | 0.3% | 21 |
|
|
2022
Q4 | $569K | Buy |
+3,521
| New | +$569K | 0.56% | 21 |
|